Pulmonx Stock Forecast for 2023 - 2025 - 2030

Updated on 05/01/2024

Stock Rating
4
Price Target
$17.00
Consensus
Outperform
Upside
123.39%
Analysts
3
Stock Rating
4
Upside
123.39%
Analysts
3
Price Target
$17.00

Pulmonx Stock Forecast and Price Target

The average target price set lately by three experts for Pulmonx to reach by the end of the year is $17.00, which would imply a potential upside of approximately 123.39 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $17.00 and a low estimate of $14.00. If you are looking to invest in the stock, it's important to research and compare different companies.

$17.00

123.39% Upside

Outperform
Outperform

Pulmonx Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Price for Pulmonx has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Pulmonx will be 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Pulmonx Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Revenue for Pulmonx has grown by 109.84%, going from $32.73M to $68.68M. In the following year, 0 experts forecast Pulmonx's Revenue will decrease by 21.35%, to $54.02M. In 2030, professionals predict that Pulmonx's Revenue will decrease by 19.05%, to $55.59M.

2024 Rev Forecast
$0.05B
2025 Rev Forecast
$0.05B
2026 Rev Forecast
$0.05B
2027 Rev Forecast
$0.06B
2028 Rev Forecast
$0.06B
2029 Rev Forecast
$0.06B
2030 Rev Forecast
$0.06B

Pulmonx Dividend per Share Forecast for 2023 - 2025 - 2030

Pulmonx Free Cash Flow Forecast for 2023 - 2025 - 2030

Pulmonx EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Pulmonx's EBITDA has grown, increasing from $-31.85M to $-60.25M – an increase of 89.17%. According to 0 analysts, Pulmonx's EBITDA will fall by 18.44% in the next year, reaching $-49.14M. Professionals believe that By 2030, Pulmonx's EBITDA will fall to $-51.72M – a 14.16% decrease from its current value.

2024 EBITDA Forecast
$-49139900.00
2025 EBITDA Forecast
$-48928598.43
2026 EBITDA Forecast
$-51838219.08
2027 EBITDA Forecast
$-54850019.61
2028 EBITDA Forecast
$-52899187.25
2029 EBITDA Forecast
$-51592577.32
2030 EBITDA Forecast
$-51718119.26

Pulmonx EBIT Forecast for 2023 - 2025 - 2030

Pulmonx's EBIT has increased by 91.59% In the last three years, going from $-32.33M to $-61.94M. In the following year, 0 experts forecast that Pulmonx's EBIT will decrease by 18.77%, to $-50.31M. In 2030, professionals predict that Pulmonx's EBIT will decrease by 14.46%, to $-52.99M.

2024 EBIT Forecast
$-50311797.33
2025 EBIT Forecast
$-50050175.99
2026 EBIT Forecast
$-53103236.72
2027 EBIT Forecast
$-56268189.63
2028 EBIT Forecast
$-54233156.77
2029 EBIT Forecast
$-52855634.59
2030 EBIT Forecast
$-52986011.82

Pulmonx EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, EPS for Pulmonx has grown by 100.00%, going from $-3.48 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Pulmonx will be 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00